首页> 外文会议>ASMS Conference on Mass Spectrometry and Allied Topics >Exploring the Detection Limits of ERG Oncoprotein in Prostate Cancer Using Different Sample Types Simulating Clinical Specimens
【24h】

Exploring the Detection Limits of ERG Oncoprotein in Prostate Cancer Using Different Sample Types Simulating Clinical Specimens

机译:用不同的样品类型探讨临床样本的不同样品癌中槲寄生癌中槲寄生蛋白的检测限

获取原文

摘要

Using PRISM-SRM, three ERG peptides were detected using purified ERG3 protein spiked into LNCaP cell lysates. Peptide VIVPADPTLWSTDHVR provided the best response, allowing ERG protein detection at the 20 pg level. PRISM-SRM allowed for detection of ERG protein from 10,000 VCaP cells spiked in LNCaP cells (simulating tissue), and from as low as 600 VCaP cells spiked in female urine (simulating urine sediment). ELISA allowed for detection of 50-100 pg of ERG3 spiked in LNCaP lysates; Western blotting and NanoString allowed for detection of ERG from ~10,000 VCap cells spiked in cell mixtures and urine sediments, respectively.
机译:使用棱镜-Srm,使用纯化的ERG3蛋白掺入LNCAP细胞裂解物中检测三个ERG肽。 肽Vivpadptlwstdhvr提供了最佳响应,允许ERG蛋白质检测在20 pg水平。 棱镜-SRM允许检测来自在LNCAP细胞(模拟组织)中掺入的10,000个VCAP细胞中的ERG蛋白质,并且低至600个VCAP细胞掺入雌性尿液(模拟尿沉积物)。 ELISA允许检测50-100pg在LNCAP裂解物中掺入的ERG3; 允许检测〜10,000 VCAP细胞中的蛋白质印迹和纳米型分别分别掺入细胞混合物和尿液沉积物中的eRG。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号